TTM
$3.03B
YoY change
+58.3%
5Y CAGR
—
Peak year (2025)
$3.11B
Cumulative EBITDA
$54.30B
EBITDA history chart for Cardinal Health (CAH) from 1986 to 2025
Latest: $3.11B
EBITDA growth chart for Cardinal Health (CAH) from 1986 to 2025
Latest: +58.3%
EBITDA history table for Cardinal Health (CAH) from 1986 to 2025
| 2025 | $3.11B | +58.3% | +$1.14B | ||
| 2024 | $1.96B | +36.3% | +$523.00M | ||
| 2023 | $1.44B | +2516.4% | +$1.38B | ||
| 2022 | $55.00M | -95.7% | −$1.23B | ||
| 2021 | $1.29B | -149.1% | +$3.91B | ||
| 2020 | −$2.62B | -186.1% | −$5.67B | ||
| 2019 | $3.04B | +168.8% | +$1.91B | ||
| 2018 | $1.13B | -60.1% | −$1.71B | ||
| 2017 | $2.84B | -8.2% | −$253.00M | ||
| 2016 | $3.10B | +20.9% | +$536.00M | ||
| 2015 | $2.56B | +7.1% | +$169.00M | ||
| 2014 | $2.39B | +69.7% | +$982.00M | ||
| 2013 | $1.41B | -33.5% | −$710.00M | ||
| 2012 | $2.12B | +10.1% | +$194.00M | ||
| 2011 | $1.92B | +21.8% | +$345.00M | ||
| 2010 | $1.58B | -3.7% | −$60.80M | ||
| 2009 | $1.64B | -1.0% | −$16.70M | ||
| 2008 | $1.66B | -9.8% | −$180.90M | ||
| 2007 | $1.84B | -17.1% | −$378.10M | ||
| 2006 | $2.22B | +0.4% | +$9.10M | ||
| 2005 | $2.21B | -18.3% | −$493.40M | ||
| 2004 | $2.70B | +4.1% | +$105.60M | ||
| 2003 | $2.59B | +17.4% | +$385.00M | ||
| 2002 | $2.21B | +25.0% | +$441.50M | ||
| 2001 | $1.77B | +15.0% | +$230.20M | ||
| 2000 | $1.54B | +20.1% | +$257.20M | ||
| 1999 | $1.28B | +18.9% | +$203.80M | ||
| 1998 | $1.08B | +16.4% | +$151.70M | ||
| 1997 | $924.80M | +177.5% | +$591.50M | ||
| 1996 | $333.30M | +16.8% | +$48.00M | ||
| 1995 | $285.30M | +177.0% | +$182.30M | ||
| 1994 | $103.00M | +55.6% | +$36.80M | ||
| 1993 | $66.20M | +24.9% | +$13.20M | ||
| 1992 | $53.00M | +34.9% | +$13.70M | ||
| 1991 | $39.30M | +40.9% | +$11.40M | ||
| 1990 | $27.90M | +32.9% | +$6.90M | ||
| 1989 | $21.00M | +40.0% | +$6.00M | ||
| 1988 | $15.00M | -6.3% | −$1.00M | ||
| 1987 | $16.00M | +53.8% | +$5.60M | ||
| 1986 | $10.40M | — | — |
- 2025$3.11B+58.3%
- 2024$1.96B+36.3%
- 2023$1.44B+2516.4%
- 2022$55.00M-95.7%
- 2021$1.29B-149.1%
- 2020−$2.62B-186.1%
- 2019$3.04B+168.8%
- 2018$1.13B-60.1%
- 2017$2.84B-8.2%
- 2016$3.10B+20.9%
- 2015$2.56B+7.1%
- 2014$2.39B+69.7%
- 2013$1.41B-33.5%
- 2012$2.12B+10.1%
- 2011$1.92B+21.8%
- 2010$1.58B-3.7%
- 2009$1.64B-1.0%
- 2008$1.66B-9.8%
- 2007$1.84B-17.1%
- 2006$2.22B+0.4%
- 2005$2.21B-18.3%
- 2004$2.70B+4.1%
- 2003$2.59B+17.4%
- 2002$2.21B+25.0%
- 2001$1.77B+15.0%
- 2000$1.54B+20.1%
- 1999$1.28B+18.9%
- 1998$1.08B+16.4%
- 1997$924.80M+177.5%
- 1996$333.30M+16.8%
- 1995$285.30M+177.0%
- 1994$103.00M+55.6%
- 1993$66.20M+24.9%
- 1992$53.00M+34.9%
- 1991$39.30M+40.9%
- 1990$27.90M+32.9%
- 1989$21.00M+40.0%
- 1988$15.00M-6.3%
- 1987$16.00M+53.8%
- 1986$10.40M—
EBITDA values are taken from Cardinal Health's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at Cardinal Health (CAH)
According to Cardinal Health's latest reported financial statements, the company's current EBITDA (TTM) is $3.03B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Cardinal Health (CAH) reported EBITDA of $3.11B – surged 58.3% year-over-year.
Across 2015–2025 (10 years), Cardinal Health EBITDA produced a CAGR of +2.0% – sustaining 3 straight years of year-over-year growth.
2025 marks the peak EBITDA at $3.11B, with the historical low of −$2.62B recorded in 2020.
Cardinal Health EBITDA by Year
Cardinal Health EBITDA 2025: $3.11B
Cardinal Health posted EBITDA of $3.11B in 2025, surged 58.3% from 2024. This figure represents the highest annual value in the available history.
Cardinal Health EBITDA 2024: $1.96B
In 2024, Cardinal Health reported EBITDA of $1.96B, surged 36.3% from 2023.
Cardinal Health EBITDA 2023: $1.44B
Cardinal Health EBITDA in 2023 was $1.44B, surged 2516.4% from 2022.
Cardinal Health EBITDA 2022: $55.00M
2022's EBITDA for Cardinal Health came in at $55.00M, plunged 95.7% below 2021.
Cardinal Health EBITDA 2021: $1.29B
Cardinal Health EBITDA in 2021 was $1.29B.
See more financial history for Cardinal Health (CAH).
Sector peers by EBITDA
Healthcare peers of Cardinal Health (CAH), ranked by their latest EBITDA
| $41.05B | |
| $28.26B | |
| $27.94B | |
| $24.43B | |
| $23.06B | |
| $19.83B | |
| $17.63B | |
| $16.90B |
- $41.05B
- $28.26B
- $27.94B
- $24.43B
- $23.06B
- $19.83B
- $17.63B
- $16.90B
Frequently asked questions
Cardinal Health (CAH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation